4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-090194
Chief Scientific Officer acquired 4,282 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Barone Francesca · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-25 | Grant or award : show line 1 in the form | +4,282 | $4.67 | $19,997 | 100,809 | D |
Loading xslF345X05/ownership.xml…